Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

Launched by EUROFEEDBACK · Oct 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of a medical device called Intense Pulsed Light (IPL) to treat various skin disorders, including excessive hairiness, vascular lesions like rosacea, pigmented lesions such as age spots, and acne. The IPL device has been approved for use since 1995 and is popular because it is cost-effective and can address multiple skin issues.

To participate in the trial, you need to be an adult (18 years and older) and meet specific criteria related to your skin type and the condition being treated. For example, if you have unwanted hair, you should have hair on areas like your legs or arms, while those interested in treating acne must have facial acne. Participants will also need to protect treated areas from the sun during and after the treatment. It’s important to note that certain individuals, including pregnant women or those with specific health conditions, may not be eligible for this trial. If you think you might qualify and are interested, this could be a good opportunity to explore a new treatment option for your skin concerns.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult men or women
• * Excessive Hairiness:
• • Patient with unwanted hair on the body (legs, arms, bikini line, or axilla)
• • Patient over 18 years.
• • Patients with Fitzpatrick skin types from I to V.
• • Women were required to be post-menopausal, surgically sterilized, or under a medically acceptable form of birth control (i.e., oral contraceptives, IUD, contraceptive implant, or barrier methods with spermicide or abstinence) during the study time period.
• Vascular lesions:
• • Patients over 18 years.
• • Patients with Fitzpatrick skin types from I to IV.
• • Patients with varicosities and Rosacea on the face or upper and lower limbs.
• Pigmented lesions:
• • Patients over 18 years.
• • Patients with solar lentigines on their cheeks, back, hands, arm and leg (\> 3 mm).
• • Patient with Fitzpatrick skin type from I to IV.
• Acne:
• • Patients over 18 years
• • Patients with Fitzpatrick skin types from I to IV.
• • Patients with facial acne vulgaris on face.
• • Willing to sun protect treated area for the duration of enrollment in the study and 4 weeks after treatment.
• Exclusion Criteria:
• • Patients with history of malignant lesions or pre-malignant lesions, scarring, or infection in the area to be treated History of keloidal or hypertrophic scarring
• • Patients with a known photosensitivity
• • Pregnancy women
• • Patient with diabetes mellitus suntan in the area to be treated
• • Use of photo-sensitizing products for 7 days before treatment (selftanning lotions, activators, self-tanning shower gel, etc.)
• • Exposure to the sun or UV rays at least 4 weeks before the treatment and 1 week afterwards
• • Zones with uncovered tattoos, suspect spots or skin diseases (including spots, inflammation, beauty spots, tumors or melanomas, psoriasis, herpes...)
• • Use of medication that induces anticoagulative medication or thromboembolic condition
• • Patients with pacemaker or internal defibrillator
• • Patients that used of NSAIDS two weeks prior to or 2 weeks following the treatment
• • Epileptic patients
• • Additional criteria for excessive hair: Patients that use waxing or other methods of photo epilation within 1 month prior to treatment.
• • Additional criteria for acne: Patients currently under oral antibiotic or oral therapy for acne.